Tag: myasthenia gravis treatment

November 26, 2025 / Mohammed looti

EDROPHONIUM

Introduction to Edrophonium Edrophonium is a potent pharmacological agent classified as a rapidly acting, reversible anticholinesterase drug. Chemically, it is a quaternary ammonium compound, a structural characteristic that critically determines its pharmacokinetic profile and mechanism of action. Its primary distinguishing features are its remarkably swift onset of action, typically manifesting within seconds of intravenous administration, […]

November 24, 2025 / Mohammed looti

NEOSTIGMINE

Introduction to Neostigmine Neostigmine, often recognized by its historical trade name, Prostigmin, is a crucial pharmaceutical agent classified as a reversible acetylcholinesterase inhibitor. This drug plays a vital role in clinical medicine, primarily within the fields of anesthesiology and neurology. Its fundamental mechanism involves enhancing cholinergic transmission throughout the peripheral nervous system by preventing the […]